Drug-Associated Risk of Subacute Cutaneous Lupus Erythematosus: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
Autor: | Yang L; Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Xie HZ; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Yang YX; Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Cui BN; Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Xiao ZS; Department of Dermatology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2024 Dec 21, pp. 12034754241303082. Date of Electronic Publication: 2024 Dec 21. |
DOI: | 10.1177/12034754241303082 |
Abstrakt: | Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
Databáze: | MEDLINE |
Externí odkaz: |